Amazon Drug Store Growth Is Not That Amazing: Evercore

The lack of excitement from consumers is "great news for drug stores, where investors have been worried about Amazon entering the market for several years," possibly crushing the retail pharmacy market, analysts led by Ross Muken and Elizabeth Anderson wrote in a separate report.

The analysts noted that worries over Amazon's penetration can be put on hold for the short-to medium-term. But drug stores will need to continue their "evolution of the front end or risk going the way of the dinosaurs," the analysts continued.

The survey may reassure investors who have continued to fret since Amazon bought online dose-sorting pharmacy PillPack Inc. last year, and continued to expand a national mail-order service presence. The tech company's steps to expand into prescription distribution is expected to put incremental pressure on CVS Health and Walgreens store sale.

— Read Walgreens CEO Says His Company Will Survive the Amazon Threat, on ThinkAdvisor.

— Connect with ThinkAdvisor Life/Health on LinkedIn and Twitter.

Copyright 2021 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.